Safety and Efficacy of PRG-2302 for Refractory or Relapsed B-cell Acute Lymphoblastic Leukemia Disease.
Clinical trial NCT06659653 · RECRUITING
Trial details
- NCT number
- NCT06659653
- Sponsor
- Tan Jie
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-24
- Primary completion
- 2027-03-31
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.